Mehmet Turgut

8PUBLICATIONS
142CO-AUTHORS
Haematological tumoursNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 25, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|Sep 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia.

Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu

|Jun 06, 2022
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Guray Saydam, Ridvan Ali, Ahmet Muzaffer Demir

|Aug 06, 2021
Evaluation of the effects of Ankaferd haemostat application on bone regeneration in rats with calvarial defects: histochemical, immunohistochemical and scintigraphic study.

M Turgut, S Karademir, H K Başaoğlu

|Dec 14, 2020
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey

Nur Soyer, Rıdvan Ali, Mehmet Turgut

Pageof 2

Frequent Collaborators

4 joint publications

Mehmet Sönmez

4 joint publications

Güray Saydam

4 joint publications

İbrahim Haznedaroğlu

3 joint publications

Funda Ceran